Search research articles
Contact Us
Filters
Showing results (61-70 of 81) with videos related to
Page
of 9
Sort By:
Pain
|
March 7, 2020
PAC1 receptor blockade reduces central nociceptive activity: new approach for primary headache?
Jan Hoffmann, Silke Miller, Margarida Martins-Oliveira, et al.
European Journal of Anaesthesiology
|
November 13, 2020
Prolonged postoperative cerebral oxygen desaturation after cardiac surgery: A prospective observational study
Luca Cioccari, Laurent Bitker, Lisa Toh, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 11, 2012
Pharmacological blockade of the cold receptor TRPM8 attenuates autonomic and behavioral cold defenses and decreases deep body temperature
M Camila Almeida, Tamara Hew-Butler, Renato N Soriano, et al.
Nature Neuroscience
|
November 29, 2011
Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses
Darren Goffin, Megan Allen, Le Zhang, et al.
Journal of Immunotherapy and Precision Oncology
|
January 16, 2025
Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study
Aung Naing, Amit Mahipal, Milind Javle, et al.
Investigational New Drugs
|
June 29, 2022
First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors
Todd Bauer, Byong Chul Cho, Rebecca Heist, et al.
Journal for Immunotherapy of Cancer
|
March 13, 2025
Myeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancer
Oladapo O Yeku, Minal Barve, Winston W Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2018
A Phase I Trial of a Guadecitabine (SGI-110) and Irinotecan in Metastatic Colorectal Cancer Patients Previously Exposed to Irinotecan
Valerie Lee, Judy Wang, Marianna Zahurak, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 24, 2004
AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties
Narender R Gavva, Rami Tamir, Yusheng Qu, et al.
BJC Reports
|
February 27, 2025
CITRINO: phase 1 dose escalation study of anti-LAG-3 antibody encelimab alone or in combination with anti-PD-1 dostarlimab in patients with advanced/metastatic solid tumours
J Randolph Hecht, Jean-Marie Michot, David Bajor, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 81) with videos related to
Sort By:
Page
of 9
Pain
|
March 7, 2020
PAC1 receptor blockade reduces central nociceptive activity: new approach for primary headache?
Jan Hoffmann, Silke Miller, Margarida Martins-Oliveira, et al.
European Journal of Anaesthesiology
|
November 13, 2020
Prolonged postoperative cerebral oxygen desaturation after cardiac surgery: A prospective observational study
Luca Cioccari, Laurent Bitker, Lisa Toh, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 11, 2012
Pharmacological blockade of the cold receptor TRPM8 attenuates autonomic and behavioral cold defenses and decreases deep body temperature
M Camila Almeida, Tamara Hew-Butler, Renato N Soriano, et al.
Nature Neuroscience
|
November 29, 2011
Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses
Darren Goffin, Megan Allen, Le Zhang, et al.
Journal of Immunotherapy and Precision Oncology
|
January 16, 2025
Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study
Aung Naing, Amit Mahipal, Milind Javle, et al.
Investigational New Drugs
|
June 29, 2022
First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors
Todd Bauer, Byong Chul Cho, Rebecca Heist, et al.
Journal for Immunotherapy of Cancer
|
March 13, 2025
Myeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancer
Oladapo O Yeku, Minal Barve, Winston W Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2018
A Phase I Trial of a Guadecitabine (SGI-110) and Irinotecan in Metastatic Colorectal Cancer Patients Previously Exposed to Irinotecan
Valerie Lee, Judy Wang, Marianna Zahurak, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 24, 2004
AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties
Narender R Gavva, Rami Tamir, Yusheng Qu, et al.
BJC Reports
|
February 27, 2025
CITRINO: phase 1 dose escalation study of anti-LAG-3 antibody encelimab alone or in combination with anti-PD-1 dostarlimab in patients with advanced/metastatic solid tumours
J Randolph Hecht, Jean-Marie Michot, David Bajor, et al.
Page
of 9